Presentations | Sutro Biopharma, Inc.

Investor Conference Call September 9, 2020 – Presentation

Investor Conference Call September 9, 2020 – Presentation To download the presentation, Click Here Download...

Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting

Events, News, Presentations, Press Releases

Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting Updated Data Further Demonstrate Promising Efficacy and Safety Profile in a Heavily Pretreated Patient Population Not Selected Based on...

Sutro Biopharma to Present at Two Upcoming Investor Conferences

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at Two Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Sept. 3, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein...

Sutro Biopharma Announces Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer and Presentation at the 2020 IGCS Annual Global Meeting

Events, News, Presentations, Press Releases

Sutro Biopharma Announces Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer and Presentation at the 2020 IGCS Annual Global Meeting Ongoing Data Further Demonstrate Promising Efficacy and Safety Profile in a Heavily Pretreated Patient Population Not...

IGCS 2020 Annual Global Meeting – Abstract

News, Presentations

IGCS 2020 Annual Global Meeting – Abstract Phase 1 Dose-Escalation Study of STRO-002, an anti-Folate Receptor alpha (FRα) Antibody Drug Conjugate (ADC), in Patients with Advanced Platinum Resistant/Refractory Epithelial Ovarian Cancer (OC). Dr. Naumann is...

Sutro Biopharma to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference SOUTH SAN FRANCISCO, Calif., August 10, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application...

« Older Entries

Next Entries »